Agronomic portal Agronom.info
Categories
Language
Currency
My account
Rapeseed

MIRAKEL

Diseases
Phomosis
Country
Germany
Registration Year
2015
Manufacturer
NPZ Lembke
No active offers.
Views
3
Reviews
0
Producer
NPZ Lembke
Description MIRAKEL
MIRAKEL — this is a medium-early hybrid of winter rapeseed (Brassica napus var. napus) type 00, characterized by the absence of erucic acid and low glucosinolate content. It starts flowering relatively early, which contributes to a prolonged flowering period and high yield formation. The vegetation period varies depending on the region and ranges from 94 to 110 days. The hybrid is adaptable to various growing conditions and suitable for cultivation on different soil types, including light and heavy soils. MIRAKEL has high resistance to lodging and pod cracking, reducing losses during harvest. The 1000-seed mass is high, further minimizing losses and improving seed quality. Disease resistance, particularly to phoma, is rated as high, ensuring stable yields even under adverse conditions. The hybrid also exhibits high drought tolerance, making it a reliable choice for regions with variable rainfall. Average seed yield over years of variety trials is about 28.2 ц/ha, with maximum yields reaching up to 46 ц/ha under favorable conditions. Oil content in the seeds ranges from 41-45%, making MIRAKEL attractive for oilseed production. Recommended sowing rate is 70-80 germinating seeds per square meter, with a medium sowing time. Plant height reaches 105-110 cm, ensuring good competitiveness against weeds and efficient resource utilization.
Specifications MIRAKEL
Diseases
Phomosis
Phomosis
Type of Rape
Spring Rapeseed
Hybrid Type
Population (Variety)
Growing Season
90-100 days
100-110 days
Yield Potential
20-30 ц/га
30-40 cu/m
40-50 ц/га
Plant: height
100-110 cm
Oil Content
40-45%
Glucosinolate Content, mmol
9-10
Erucic Acid Content
Low
Country
Germany
Registration Year
2015
Catalog
Varieties
Technical Crops
Manufacturer
NPZ Lembke
Where to buy MIRAKEL
Loading...
Reviews MIRAKEL
0comments
Sort by:Popular first
No comments yet.